Prevention of cerebral thrombosis

Prevention of cerebral thrombosis refers to prophylactic antithrombotic intervention aimed at averting in situ blood clot formation within the cerebral arterial circulation or, less commonly, the cerebral venous sinuses

Prevention of cerebral thrombosis refers to prophylactic antithrombotic intervention aimed at averting in situ blood clot formation within the cerebral arterial circulation or, less commonly, the cerebral venous sinuses This clinical indication predominantly targets individuals at high risk for atherothrombotic ischemic stroke, such as patients with severe intracranial or extracranial atherosclerosis, a history of transient ischemic attacks, prior noncardioembolic stroke, or evolving cerebrovasc...

This clinical indication predominantly targets individuals at high risk for atherothrombotic ischemic stroke, such as patients with severe intracranial or extracranial atherosclerosis, a history of transient ischemic attacks, prior noncardioembolic stroke, or evolving cerebrovascular occlusion

This clinical indication predominantly targets individuals at high risk for atherothrombotic ischemic stroke, such as patients with severe intracranial or extracranial atherosclerosis, a history of transient ischemic attacks, prior noncardioembolic stroke, or evolving cerebrovascular occlusion

Pathophysiologically, the targeted event involves endothelial injury, plaque rupture, platelet activation, and subsequent fibrin mesh deposition that acutely occlude downstream cerebral blood flow

Pathophysiologically, the targeted event involves endothelial injury, plaque rupture, platelet activation, and subsequent fibrin mesh deposition that acutely occlude downstream cerebral blood flow